1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM5®). American Psychiatric Pub; 2013.

2. Fairbrother N, Young AH, Zhang A, Janssen P, Antony MM. The prevalence and incidence of perinatal anxiety disorders among women experiencing a medically complicated pregnancy. Mental Health 2017; 20(2): 311-9.

3. Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Hendriks GJ, et al. The relationship between cognitions and symptoms in obsessive-compulsive disorder. J Affect Disor 2018; 225: 495-502.

4. Goldfarb EV, Froböse MI, Cools R, Phelps EA. Stress and cognitive flexibility: cortisol increases are associated with enhanced updating but impaired switching. J Cogn Neuro Sci 2017; 29(1): 14-24.

5. Fisher PL, Wells A. Metacognitive therapy for obsessive–compulsive disorder: A case series. J Behav Ther Psychiatry 2008; 39(2): 117-32.

6. Shareh H, Gharraee B, Atef VMK, Eftekhar M et al. Metacognitive therapy (MCT), fluvoxamine, and combined treatment in improving obsessive-compulsive, depressive and anxiety symptoms in patients with obsessive-compulsive disorder (OCD). Brain Res 2010; 935(1-2): 40-6.

7. Rees CS, van Koesveld KE. An open trial of group metacognitive therapy for obsessive-compulsive disorder.J Behav Ther 2008; 39(4): 451-8.

8. Moritz S, Von Mühlenen A, Randjbar S, Fricke S, Jelinek L, et al. Evidence for an attentional bias for washing-and checking-relevant stimuli in obsessive–compulsive disorder. J Neuro Psychol Society 2009; 15(3): 365-71.

9. Moritz S, Jelinek L, Hauschildt M, Naber D. How to treat the untreated: effectiveness of a self-help metacognitive training program (myMCT) for obsessive-compulsive disorder. Dialog Neuro Sci 2010; 12(2): 209.

10. Asl Alavi Paidar S, Khodabakhsh RM, Seyed Abolghasem Comparison of the effectiveness of behavioural-cognitive & behavioural-metacognitive approaches in patients with obsessive-compulsive disorder [OCD]. Tehran. Alzahra University. 2010.

11. Moritz S, Fink J, Miegel F, Nitsche K, Kraft V, Tonn P, et al. Obsessive–Compulsive Disorder is Characterized by a Lack of Adaptive Coping Rather than an Excess of Maladaptive Coping. Cogn Ther Res 2018; 42(5): 650-60.

12. Moritz S, Lysaker PH. Metacognition–what did James H. Flavell really say and the implications for the conceptualization and design of metacognitive interventions. Schizophr Res 2018; 201: 20-6.

13. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, et al. Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. General Psychiatry 2009; 1.279(14): 297-7.

14. Wells A. Emotional disorders and metacognition: innovative cognitive therapy. New York: John Wiley & Sons; 2002. p. 78-9

15. Esfahani SR, Motaghipour Y, Kamkari K, Zahiredin A, Janbozorgi M, et al. Reliability and Validity of the Persian Version of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Iran J Clin Psychol 2012; 17(4): 97-8

16. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998; 279(14): 1100-7.

17. Hauschildt M, Schröder J, Moritz S. Randomized-controlled trial on a novel (meta-) cognitive self-help approach for obsessive-compulsive disorder (“myMCT”). J OCD Disor 2016; 10: 26-34.

18. Moritz S, Irshaid S, Beiner A, Hauschildt M, Miegel F. Acceptance and efficacy of a metacognitive self-help intervention in an Arabic-speaking mixed patient sample with depression and/or obsessive–compulsive disorder: A randomized controlled trial. J Experi Psychol 2019; 10(1): 2043808718820683.

19. Pascual-Vera B, Roncero M, Doron G, Belloch A. Assisting relapse prevention in OCD using a novel mobile app–based intervention: J Menning Clin 2018; 8.279(14): 225-4.